NEW YORK — BioEcho Life Sciences said on Monday that it has received CE-IVD marking for its EchoLution Viral RNA/DNA Swab Kit.
According to the German company, the kit enables the purification of viral RNA, including SARS-CoV-2 RNA, in five minutes and is compatible with commonly available transport media.
BioEcho, based in Cologne, was founded in 2016 by former Qiagen employees to commercialize a sample prep technology, dubbed reverse chromatography-based nucleic acid purification, in which the separation matrix binds everything except the nucleic acid. The firm had originally been using the technology only for DNA purification but developed an RNA extraction protocol for use with COVID-19 samples when the SARS-CoV-2 pandemic hit Germany.